These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34601504)

  • 1. Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation.
    Gibson SE; Liu YC; Yatsenko SA; Barasch NJ; Swerdlow SH
    Mod Pathol; 2022 Jan; 35(1):60-68. PubMed ID: 34601504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular lymphomas with plasmacytic differentiation include two subtypes.
    Gradowski JF; Jaffe ES; Warnke RA; Pittaluga S; Surti U; Gole LA; Swerdlow SH
    Mod Pathol; 2010 Jan; 23(1):71-9. PubMed ID: 19838161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
    Horn H; Schmelter C; Leich E; Salaverria I; Katzenberger T; Ott MM; Kalla J; Romero M; Siebert R; Rosenwald A; Ott G
    Haematologica; 2011 Sep; 96(9):1327-34. PubMed ID: 21659362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.
    Carreras J; Ikoma H; Kikuti YY; Miyaoka M; Hiraiwa S; Tomita S; Kondo Y; Ito A; Nagase S; Miura H; Kawada H; Roncador G; Campo E; Hamoudi R; Nakamura N
    Virchows Arch; 2024 Apr; 484(4):657-676. PubMed ID: 38462571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular lymphoma with prominent Dutcher body formation: a pathologic study of 3 cases in comparison with nodal or splenic lymphoplasmacytic lymphoma and marginal zone lymphoma.
    Wang E; Stoecker M; Burchette J; Rehder C
    Hum Pathol; 2012 Nov; 43(11):2001-11. PubMed ID: 22607703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components.
    Kelley JT; Brown NA; Hristov AC; Bresler SC
    J Cutan Pathol; 2021 Jul; 48(7):969-974. PubMed ID: 33786907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution.
    Lim S; Koh J; Bae JM; Yun H; Lee C; Paik JH; Kim TM; Jeon YK
    Diagn Pathol; 2024 Jun; 19(1):86. PubMed ID: 38909266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare face of follicular lymphoma: reverse variant of follicular lymphoma.
    Maskey N; Chen Q; Liu F; Liu S; Tian S
    Diagn Pathol; 2020 Apr; 15(1):31. PubMed ID: 32245492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
    Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
    Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.
    Karube K; Guo Y; Suzumiya J; Sugita Y; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Takeshita M; Kikuchi M; Nakamura N; Takasu O; Arakawa F; Tagawa H; Seto M; Ohshima K
    Blood; 2007 Apr; 109(7):3076-9. PubMed ID: 17138820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
    Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
    Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
    Moore EM; Swerdlow SH; Gibson SE
    Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma.
    Ree HJ; Kadin ME; Kikuchi M; Ko YH; Suzumiya J; Go JH
    Hum Pathol; 1999 Apr; 30(4):403-11. PubMed ID: 10208461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma.
    Dyhdalo KS; Lanigan C; Tubbs RR; Cook JR
    Am J Clin Pathol; 2013 Aug; 140(2):149-54. PubMed ID: 23897248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.
    Ikoma H; Miyaoka M; Hiraiwa S; Yukie Kikuti Y; Shiraiwa S; Hara R; Kojima M; Ohmachi K; Ando K; Carreras J; Nakamura N
    Pathol Int; 2022 Jun; 72(6):321-331. PubMed ID: 35297566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
    Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
    Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
    Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
    Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B.
    Laurent C; Adélaïde J; Guille A; Tesson B; Gat E; Evrard S; Escudié F; Syrykh C; Canioni D; Fabiani B; Meignin V; Chassagne-Clement C; Dartigues P; Traverse-Glehen A; Parrens M; Huet S; Copie-Bergman C; Salles G; Birnbaum D; Brousset P; Morschhauser F; Xerri L;
    Am J Surg Pathol; 2021 Oct; 45(10):1324-1336. PubMed ID: 34334687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.